One of the leading manufacturers of the coronavirus vaccine in the world ‘Serum Institute of India’ has said that it will ‘Covishield’ at ₹ 400 to state governments and ₹ 600 per dose respectively to private hospitals. It is not yet clear so as to how much over this cost private hospital will charge for those eligible for vaccinations.
The announcement came two days after the Centre decided to open up vaccinations against COVID-19 to those above the age of 18 years, and also liberalized the vaccination drive to allow states, private hospitals, and industrial establishments to procure the doses directly from manufacturers.
As per the Centre’s decision, around 50 percent of the doses produced by vaccine makers will be provided “in the open market” at a pre-declared price. India alone needs 630 million doses of covid vaccine in just the current phase – and also almost, 92 countries are dependent on supplies from this vaccine company in India. Poonawalla had also reached out to US President Joe Biden urging him to lift the embargo on raw materials which are needed to produce a vaccine.
Based on this price, state governments, private hospitals, industrial establishments, etc., would be able to procure vaccine doses from the manufacturers. Private Hospitals would have to procure their supplies of Covid-19 vaccine exclusively from the 50% supply earmarked for other than the Govt of India channel. Private vaccination providers shall transparently declare their self-set vaccination price.